@Article{信息:doi 10.2196 / /移动医疗。4930,作者=“Firth, Joseph和Torous, John”,标题=“精神分裂症的智能手机应用程序:系统综述”,期刊=“JMIR mHealth uHealth”,年=“2015”,月=“11”,日=“06”,卷=“3”,号=“4”,页=“e102”,关键词=“eHealth”;健身;移动健康;精神病;精神分裂症;智能手机;技术;背景:人们对使用智能手机等移动技术来改善精神分裂症患者的护理越来越感兴趣。然而,目前对智能手机应用程序在这一人群中的可行性和有效性的临床证据知之甚少。 Objective: To review the published literature of smartphone apps applied for the care of patients with schizophrenia and other psychotic disorders. Methods: An electronic database search of Ovid MEDLINE, the Cochrane Central Register of Controlled Trials, Health Technology Assessment Database, Allied and Complementary Medicine, Health and Psychosocial Instruments, PsycINFO, and Embase was conducted on May 24, 2015. All eligible studies were systematically reviewed, and proportional meta-analyses were applied to pooled data on recruitment, retention, and adherence to examine the overall feasibility of smartphone interventions for schizophrenia. Results: Our search produced 226 results from which 7 eligible articles were identified, reporting on 5 studies of smartphone apps for patients with schizophrenia. All examined feasibility, and one assessed the preliminary efficacy of a smartphone intervention for schizophrenia. Study lengths varied between 6 and 130 days. Overall retention was 92{\%} (95{\%} CI 82-98{\%}). Participants consistently used the smartphone apps on more than 85{\%} of days during the study period, averaging 3.95 interactions per person per day. Furthermore, participants responded to 71.9{\%} of automated prompts (95{\%} CI 65.7-77.8{\%}). Participants reported a range of potential benefits from the various interventions, and user experience was largely positive. Conclusions: Although small, the current published literature demonstrates strong evidence for the feasibility of using smartphones to enhance the care of people with schizophrenia. High rates of engagement and satisfaction with a broad range of apps suggest the nascent potential of this mobile technology. However, there remains limited data on the efficacy of such interventions. ", issn="2291-5222", doi="10.2196/mhealth.4930", url="http://mhealth.www.mybigtv.com/2015/4/e102/", url="https://doi.org/10.2196/mhealth.4930", url="http://www.ncbi.nlm.nih.gov/pubmed/26546039" }
Baidu
map